Search
Patexia Research
Case number IPR2017-01923

Pfizer, Inc. v. Genentech, Inc. > Documents

Date Field Doc. No.PartyDescription
May 16, 2019 113 GENENTECH, INC¿¿¿S UNOPPOSED MOTION TO EXPUNGE Download
May 15, 2019 112 ORDER Granting Patent Owner's Renewed Motion to Seal Download
Apr 17, 2019 1060 Ex 1060 - Deposition of Benyunes, Mark - REDACTED Download
Apr 17, 2019 1074 Petitioner Oral Argument Demonstratives 1-15-19 - REDACTED Download
Apr 16, 2019 2062 Ex. 2062 PUBLIC 2002-06-10 Minutes of London meeting Download
Apr 16, 2019 2044 EX 2044 PUBLIC 2001-07-03 Slides of development scenarios Download
Apr 16, 2019 2047 EX 2047 PUBLIC 2001-09-27 PPC Slides - Draft Download
Apr 16, 2019 2067 EX 2067 PUBLIC 2002-07-02 Email from Joanne Quan Download
Apr 16, 2019 2019 EX 2019 PUBLIC 2000-05-09 Videoconference Minutes Download
Apr 16, 2019 2043 EX 2043 PUBLIC 2001-07-03 Development scenarios Download
Apr 16, 2019 2021 EX 2021 PUBLIC 2000-10-26 Protocol WA16291B Download
Apr 16, 2019 2022 EX 2022 PUBLIC Investigator Agreements for Edwards Download
Apr 16, 2019 2038 EX 2038 PUBLIC 2001-05-23 Protocol WA16291C Download
Apr 16, 2019 2055 EX 2055 PUBLIC 2002-05-29 Email from Mark Benyunes Download
Apr 16, 2019 2015 EX 2015 - PUBLIC 1999-11-03 Meeting minutes Download
Apr 16, 2019 2042 EX 2042 PUBLIC 2001-07-03 Email from Tim Shaw Download
Apr 16, 2019 2049 EX 2049 PUBLIC 2001-11-01 Email from Mark Benyunes Download
Apr 16, 2019 2060 EX 2060 PUBLIC 2002-06 Protocol Concept Sheet Download
Apr 16, 2019 2053 EX 2053 PUBLIC 2002-03-11 Rituxan Core Team Meeting Minutes Download
Apr 16, 2019 2031 EX 2031 PUBLIC Investigator Agreements for Paul Emery Download
Apr 16, 2019 2059 EX 2059 PUBLIC 2002-05-29 Q and A for interim results Download
Apr 16, 2019 2070 EX 2070 PUBLIC 2002-09-04 Pre-meeting Package - PMP Download
Apr 16, 2019 2046 EX 2046 PUBLIC 2001-09-28 PPC Slides Download
Apr 16, 2019 2040 EX 2040 PUBLIC 2001-05-30 Development scenarios Download
Apr 16, 2019 2052 EX 2052 PUBLIC 2002-03-10 Email from Mark Benyunes Download
Apr 16, 2019 2050 EX 2050 PUBLIC 2002-01-08 Project team minutes Download
Apr 16, 2019 2071 EX 2071 PUBLIC Excerpt of clinical database Download
Apr 16, 2019 2075 EX 2075 PUBLIC 2002-12-23 Email from Linda Robertson Download
Apr 16, 2019 2036 EX 2036 PUBLIC 2001-05-22 Email from Tim Shaw Download
Apr 16, 2019 2051 EX 2051 PUBLIC 2002-01-23 Protocol WA16291D Download
Apr 16, 2019 2028 EX 2028 PUBLIC Investigator Agreements for WW Bolten Download
Apr 16, 2019 2034 EX 2034 PUBLIC 2001-05-21 Email from Tim Shaw Download
Apr 16, 2019 2037 EX 2037 PUBLIC 2001-05-02 Meeting minutes Download
Apr 16, 2019 2020 EX 2020 PUBLIC 2000-09-22 Protocol WA16291A Download
Apr 16, 2019 2063 EX 2063 PUBLIC 2002-06-13 Email from Tim Breen Download
Apr 16, 2019 111 Genentech, Inc's Unopposed Renewed Motion to Seal Download
Apr 16, 2019 2024 EX 2024 PUBLIC Investigator Agreements for Szczepanski Download
Apr 16, 2019 2061 EX 2061 PUBLIC 2002-06-10 Summary of London meeting Download
Apr 16, 2019 2072 EX 2072 PUBLIC 2002-11-11 Email from Linda Robertson Download
Apr 16, 2019 2068 EX 2068 PUBLIC 2002-07-03 Email from Mark Benyunes Download
Apr 16, 2019 2032 EX 2032 PUBLIC 2001-05-08 Email from Tim Shaw Download
Apr 16, 2019 2030 EX 2030 PUBLIC Investigator Agreements for Roberto Cattaneo Download
Apr 16, 2019 2029 EX 2029 PUBLIC Investigator Agreements for Martin Mola Download
Apr 16, 2019 2035 EX 2035 PUBLIC 2001-05-21 Schedule of meetings Download
Apr 16, 2019 2065 EX 2065 PUBLIC 2002-06-27 DRAM-Interim Download
Apr 16, 2019 2039 EX 2039 PUBLIC 2001-05-30 Email from Tim Shaw Download
Apr 16, 2019 2045 EX 2045 PUBLIC 2001-07-17 Email from Tim Shaw Download
Apr 16, 2019 2073 EX 2073 PUBLIC 2002-10-29 Letter from FDA Download
Apr 16, 2019 2074 EX 2074 PUBLIC 2002-07-01 SOP Data Handling Procedures Download
Apr 16, 2019 2025 EX 2025 PUBLIC Investigator Agreements for Szechinski Download
Apr 16, 2019 2018 EX 2018 PUBLIC 2000-05 Product Development Plan PDP Download
Apr 16, 2019 2064 EX 2064 PUBLIC 2002-06-14 Email from Tim Breen Download
Apr 16, 2019 2033 EX 2033 PUBLIC 2001-05-08 Synposis WA16291 Download
Apr 16, 2019 2027 EX 2027 PUBLIC Investigator Agreements for Eric Veys Download
Apr 16, 2019 2023 EX 2023 PUBLIC Investigator Agreements for Filipowicz Download
Apr 16, 2019 2048 EX 2048 PUBLIC 2001-09-28 PPC Minutes Download
Apr 16, 2019 2041 EX 2041 PUBLIC 2001-07-02 Email from Mark Benyunes Download
Apr 16, 2019 2026 EX 2026 PUBLIC Investigator Agreements for FC Breedveld Download
Apr 16, 2019 2054 EX 2054 PUBLIC Excerpt of Quan notes Download
Apr 16, 2019 2056 EX 2056 PUBLIC Snippet of metadata for PPC slides Download
Apr 16, 2019 2066 EX 2066 PUBLIC Excerpt of Quan notes Download
Apr 16, 2019 2069 EX 2069 PUBLIC 2002-08-01 EC Presentation Download
Apr 16, 2019 2080 EX 2080 PUBLIC Declaration of Benyunes Download
Apr 2, 2019 109 Termination of the Proceeding Due to Settlement after Institution With Respect to Petitioner Only Download
Apr 2, 2019 110 Termination Decision Document Download
Mar 26, 2019 106 Patent Owner Genentech, Inc. and Petitioner Pfizer Inc.'s Joint Motion to Terminate Pursuant to 35 U.S.C. ¿¿ 317 Download
Mar 26, 2019 107 Patent Owner Genentech, Inc. and Petitioner Pfizer Inc.'s Joint Request to Treat Settlement Agreement as Business Confidential Information Pursuant to 35 U.S.C. ¿¿ 317 Download
Mar 26, 2019 108 Petitioner's Updated List of Exhibits (As of March 26, 2019) Download
Mar 1, 2019 105 Hearing Transcript - Confidential Download
Jan 16, 2019 2115 PUBLIC - EX. 2115 - Patent Owner's Demonstrative Slides Download
Jan 16, 2019 2115 PUBLIC - EX. 2115 - Patent Owner's Demonstrative Slides Download
Jan 16, 2019 104 Amending Grant of Request for Oral Argument 37 C.F.R. §§ 42.5 Download
Jan 16, 2019 103 ORDER Denying Patent Owner¿¿¿s Motion to Strike Download
Jan 16, 2019 2115 SEALED - EX. 2115 - Patent Owner's Demonstrative Slides Download
Jan 15, 2019 97 Patent Owner's Unopposed Motion to Seal Demonstrative Exhibits Download
Jan 15, 2019 96 Petitioner's Objections to Oral Argument Demonstratives Download
Jan 15, 2019 98 Patent Owner's List of Exhibits Dated January 15, 2019 Download
Jan 15, 2019 99 PUBLIC - Patent Owner's Demonstrative Slides Download
Jan 15, 2019 1074 Ex. 1074 - Petitioner's Oral Argument Demonstratives - Redacted Download
Jan 15, 2019 1074 Ex. 1074 - Petitioner's Oral Argument Demonstratives - Redacted Download
Jan 15, 2019 101 PUBLIC - Patent Owner's Objections to Petitioner's Demonstratives Download
Jan 9, 2019 94 Patent Owner's Reply in Support of its Motion to Exclude Download
Jan 9, 2019 95 Petitioner's Reply In Support of Petitioner's Motion to Exclude Download
Jan 4, 2019 93 Petitioner's Opposition to Patent Owner's Motion to Strike Download
Jan 4, 2019 1073 Ex. 1073 - Email from M. Raymond to J. Scheibeler, Nov. 15, 2018 Download
Jan 4, 2019 1072 Ex. 1072 - Declaration of John Scheibeler in Support of Petitioner's Opposition to Patent Owner's Motion to Strike Download
Dec 21, 2018 90 Patent Owner's Motion to Strike Download
Dec 21, 2018 91 Patent Owner's Opposition to Petitioner's Motion to Exclude Download
Dec 21, 2018 92 Petitioner's Opposition to Patent Owner's Motion to Exclude Download
Dec 21, 2018 1068 Email from C. Parker to J. Scheibeler, Nov. 28, 2018 Download
Dec 21, 2018 1069 Email from J. Scheibeler to S. Baughman, Nov. 29, 2018 Download
Dec 21, 2018 1070 Deposition Transcript of Professor Jonathan Charles Wright Edwards, 9/22/2017, Celltrion Inc. v. Genentech, Inc. and Biogen, Inc., IPR2016-01614 (U.S. Patent No. 7,820,161), Ex. 2092 Download
Dec 21, 2018 1071 Declaration of John Scheibeler in Support of Petitioner's Opposition to Patent Owner's Motion to Exclude Download
Dec 19, 2018 89 Petitioner's Updated Mandatory Notice Download
Dec 19, 2018 87 ORDER Granting Patent Owner¿¿¿s Request for Authorization to File a Motion to Strike Download
Dec 19, 2018 88 ORDER Granting Requests for Oral Argument Download
Dec 18, 2018 84 Patent Owner's December 18, 2018 Motion to Seal Download
Dec 18, 2018 86 PUBLIC Patent Owner's Sur-Reply Download
Dec 18, 2018 83 ORDER Terminating Inter Partes Review After Institution With Respect to Petitioner Celltrion, Inc. Due to Settlement Download
Dec 18, 2018 85 SEALED Patent Owner's Sur-Reply Download
Dec 14, 2018 82 Patent Owner's Motion to Exclude Download
Dec 14, 2018 2108 EX 2108 - November 19, 2018 Email from J. Scheibeler to M. Raymond Download
Dec 14, 2018 2113 EX 2113 - U.S. Patent No. 7,820,161 Download
Dec 14, 2018 2111 EX 2111 - December 11, 2018 Email between J. Scheibeler and J. Edwards Download
Dec 14, 2018 2114 EX 2114 - Declaration of Megan Raymond Download
Dec 14, 2018 81 Petitioner's Motion to Exclude Evidence Download
Dec 14, 2018 2112 EX 2112 - December 12, 2018 Email from S. Baughman to Board Download
Dec 14, 2018 2110 EX 2110 - November 29, 2018 emails from J. Scheibeler Download
Dec 14, 2018 2109 EX 2109 - November 26, 2018 Email from J. Scheibeler to M. Raymond Download
Dec 14, 2018 2107 EX 2107 - November 16, 2018 Email from M. Raymond to J. Scheibeler Download
Dec 14, 2018 2104 EX 2104 - USPTO December 6, 2018 "Boardside Chat" Presentation Download
Dec 14, 2018 2105 EX 2105 - November 10, 2018 Email from M. Raymond to J. Scheibeler Download
Dec 14, 2018 2106 EX 2106 - November 12, 2018 Email from J. Scheibeler to M. Raymond Download
Dec 10, 2018 78 Patent Owner's December 10, 2018 Updated Exhibit List Download
Dec 10, 2018 79 Patent Owner and Petitioner Celltrion, Inc.'s Unopposed Joint Motion to Terminate Petitioner Celltrion Download
Dec 10, 2018 80 Patent Owner and Petitioner Celltrion, Inc.'s Joint Request to Treat Settlement Agreement as Business Confidential Information Download
Dec 7, 2018 77 Petitioner's Request for Oral Argument Download
Dec 5, 2018 76 Patent Owner's Request for Oral Argument Download
Dec 5, 2018 75 Joint Stipulation to Modify Due Date 4B Download
Nov 28, 2018 74 Patent Owner's Objections to Evidence Download
Nov 20, 2018 72 Order Granting Patent Owner¿¿¿s Request for Authorization to File a Sur-Reply Download
Nov 20, 2018 73 Order Authorizing the Filing of a Joint Motion to Terminate Download
Nov 16, 2018 68 Notice of November 30, 2018 Deposition of Elena M. Massarotti, M.D. Download
Nov 16, 2018 70 Public Redacted - Petitioner's Reply to Patent Owner's Response Download
Nov 16, 2018 71 Petitioner's Motion to Seal Download
Nov 16, 2018 69 SEALED - Petitioner's Reply to Patent Owner's Response Download
Nov 16, 2018 1059 Ex. 1059 - Declaration of Jonathan Edwards - IPR2016-01614 Download
Nov 16, 2018 1067 Ex. 1067 - SEALED Supplemental Declaration of Elena M. Massarotti Download
Nov 16, 2018 1066 Ex. 1066 - SEALED Deposition Transcript of Gregg Silverman Download
Nov 16, 2018 1062 Ex. 1062 - SEALED Deposition Transcript of Timothy Shaw Download
Nov 16, 2018 1061 Ex. 1061 SEALED - Deposition Transcript of Randall Stevens Download
Nov 16, 2018 1065 Ex. 1065 - SEALED Deposition Transcript of Urs Schleuniger Download
Nov 16, 2018 1063 Ex. 1063 - SEALED Deposition Transcript of Joanne Quan Download
Nov 16, 2018 1067 Ex. 1067 - SEALED Supplemental Declaration of Elena M. Massarotti Download
Nov 16, 2018 1064 Ex. 1064 - SEALED Deposition Transcript of Eva Hessey Download
Nov 16, 2018 1067 Ex. 1067 - REDACTED Supplemental Declaration of Elena M. Massarotti Download
Nov 14, 2018 67 ORDER - Conduct of the Proceeding 37 C.F.R. § 42.5 Download
Nov 12, 2018 2085 Ex. 2085 Re-submitted Redacted Declaration of Urs Schleuniger Download
Nov 12, 2018 2085 Ex. 2085 Re-submitted Redacted Declaration of Urs Schleuniger Download
Nov 12, 2018 2080 Ex. 2080 Re-submitted Redacted Decl. of Mark Benyunes Download
Nov 12, 2018 2081 Ex. 2081 Re-submitted Redacted Declaration of Eva Hessey Download
Nov 12, 2018 2082 Ex. 2082 Re-submitted Redacted Declaration of Stacie Knight Download
Nov 12, 2018 2084 Ex. 2084 Re-submitted Redacted Declaration of Joanne Quan Download
Nov 12, 2018 2086 Ex. 2086 Re-submitted Redacted Declaration of Tim Shaw Download
Nov 12, 2018 2087 Ex. 2087 Re-submitted Redacted Declaration of Randall Stevens Download
Nov 12, 2018 2090 Ex. 2090 Re-submitted Redacted Declaration of Marc Watrous Download
Nov 12, 2018 63 Genentech, Inc.'s November 12, 2018 Motion to Seal Download
Nov 12, 2018 64 Genentech, Inc.'s November 12, 2018 Motion to Seal Responding to IPR2018-01019 Paper 12 Download
Nov 12, 2018 65 Re-submitted Redacted Patent Owner Response (IPR2017-01923) Download
Nov 12, 2018 66 Re-submitted Redacted Patent Owner's Preliminary Response from IPR2018-01019 Download
Nov 9, 2018 62 Joint Stipulation to Modify Due Date 2 Download
Oct 31, 2018 61 ORDER - Granting Motion for Entry of Modified Protective Order Granting-in-Part Patent Owner's Motion to Seal 35 U.S.C. § 316; 37 C.F.R. §§ 42.14, 42.54 Download
Oct 30, 2018 60 Decision Granting Petitioner's Motion for Pro Hac ViceAdmission of Ms. Jeannine Yoo Sano Download
Oct 1, 2018 59 Corrected Notice of Deposition of Urs Schleuniger Download
Oct 1, 2018 58 Notice of Deposition of Joanne Quan Download
Sep 21, 2018 53 Notice of Deposition of Eva Hessey Download
Sep 21, 2018 57 Notice of Deposition of Randall M. Stevens Download
Sep 21, 2018 56 Notice of Deposition of Gregg J. Silverman Download
Sep 21, 2018 54 Notice of Deposition of Urs Schleuniger Download
Sep 21, 2018 55 Notice of Deposition of Tim Shaw Download
Sep 18, 2018 52 Order - Conduct of the Proceeding - 37 CFR 42.5 Download
Sep 6, 2018 49 Petitioner's Unopposed Motion for Pro Hac Vice Admission of Jeannine Yoo Sano Under 37 C.F.R. section 42.10(c) Download
Sep 6, 2018 50 Petitioner's Updated Exhibit List (as of September 6, 2018) Download
Sep 6, 2018 51 Petitioner's Updated Mandatory Notice Pursuant to 37 C.F.R. Section 42.8 Download
Sep 6, 2018 1058 Declaration of Jeannine Yoo Sano in Support of Petitioner's Motion for Pro Hac Vice Admission Pursuant to 37 C.F.R. section 42.10(c) Download
Aug 29, 2018 48 Notice of Deposition of Mark C. Benyunes Download
Aug 22, 2018 47 Petitioner's Objections to Exhibits Download
Aug 21, 2018 46 Joint Stipulation to Modify Due Dates 1 and 2 Download
Aug 9, 2018 45 Patent Owner's Response Download
Aug 9, 2018 43 Patent Owner's Motion to Seal and for Entry of a Protective Order Download
Aug 9, 2018 44 Patent Owner's Response Download
Aug 9, 2018 2081 EX2081 - REDACTED Declaration of Eva Hessey Download
Aug 9, 2018 2066 EX2066 - REDACTED Excerpt of Quan notes Download
Aug 9, 2018 2102 EX2102 - PDR 2001 Rituximab Download
Aug 9, 2018 2090 EX2090 - SEALED Declaration of Marc Watrous Download
Aug 9, 2018 2095 EX2095 - Declaration of Gregg Silverman Download
Aug 9, 2018 2083 EX2083 - Declaration of Stephanie Mendelsohn Download
Aug 9, 2018 2014 EX2014 - 1999 Genentech - Roche collaboration agreement S-3A Download
Aug 9, 2018 2091 EX2091 - Declaration of David Chang Download
Aug 9, 2018 2100 EX2100 - Stipulated Protective Order Download
Aug 9, 2018 2086 EX2086 - REDACTED Declaration of Tim Shaw Download
Aug 9, 2018 2077 EX2077 - Rituxan Label Download
Aug 9, 2018 2098 EX2098 - Gregersen Download
Aug 9, 2018 2054 EX2054 - REDACTED Excerpt of Quan notes Download
Aug 9, 2018 2078 EX2078 - Declaration of Robert Ferraro Download
Aug 9, 2018 2076 EX2076 - ClinicalTrials.gov page for Study WA16291 Download
Aug 9, 2018 2088 EX2088 - Provisional Patent Application No. 60/461,481 Download
Aug 9, 2018 2101 EX2101 - Fusconi Download
Aug 9, 2018 2080 EX2080 - REDACTED Declaration of Mark Benyunes Download
Aug 9, 2018 2093 EX2093 - Deposition Transcript of Michael Grossbard Download
Aug 9, 2018 2099 EX2099 - Wolfe Download
Aug 9, 2018 2057 EX2057 - SEALED Snippet of metadata for Interim Data Reporting and Analysis Manual (DRAM) Download
Aug 9, 2018 2087 EX2087 - SEALED Declaration of Randall Stevens Download
Aug 9, 2018 2013 EX2013 - 1999 Genentech S-3A SEC filing Download
Aug 9, 2018 2058 EX2058 - 2002-05-29 Abstract of interim results Download
Aug 9, 2018 2097 EX2097 - Firestein Download
Aug 9, 2018 2069 EX2069 - REDACTED 2002-08-01 EC Presentation Download
Aug 9, 2018 2096 EX2096 - Janeway Download
Aug 9, 2018 2092 EX2092 - US Patent 7,976,838 Download
Aug 9, 2018 2056 EX2056 - REDACTED Snippet of metadata for PPC slides Download
Aug 9, 2018 2012 EX2012 - 1995 Genentech-IDEC Collaboration Agreement Download
Aug 9, 2018 2079 EX2079 - Declaration of Katherine Nolan-Stevaux Download
Aug 9, 2018 2094 EX2094 - Deposition Transcript of Elena Massarotti Download
Aug 9, 2018 2082 EX2082 - SEALED Declaration of Stacie Knight Download
Aug 9, 2018 2066 EX2066 - REDACTED Excerpt of Quan notes Download
Aug 9, 2018 2080 EX2080 - REDACTED Declaration of Mark Benyunes Download
Aug 9, 2018 2056 EX2056 - REDACTED Snippet of metadata for PPC slides Download
Aug 9, 2018 2069 EX2069 - REDACTED 2002-08-01 EC Presentation Download
Aug 9, 2018 2054 EX2054 - REDACTED Excerpt of Quan notes Download
Aug 9, 2018 2086 EX2086 - REDACTED Declaration of Tim Shaw Download
Aug 9, 2018 2081 EX2081 - REDACTED Declaration of Eva Hessey Download
Aug 9, 2018 2090 EX2090 - SEALED Declaration of Marc Watrous Download
Aug 9, 2018 2082 EX2082 - SEALED Declaration of Stacie Knight Download
Aug 9, 2018 2016 EX2016 - SEALED Participants List - RA CDP Review Meeting Download
Aug 9, 2018 2017 EX2017 - SEALED Participants List - RA PDP Prototyping Meeting Download
Aug 9, 2018 2087 EX2087 - SEALED Declaration of Randall Stevens Download
Aug 9, 2018 2084 EX2084 - REDACTED Declaration of Joanne Quan Download
Aug 9, 2018 2057 EX2057 - SEALED Snippet of metadata for Interim Data Reporting and Analysis Manual (DRAM) Download
Aug 9, 2018 2057 EX2057 - REDACTED Snippet of DRAM metadata Download
Aug 9, 2018 2081 EX2081 - SEALED Declaration of Eva Hessey Download
Aug 9, 2018 2082 EX2082 - REDACTED Declaration of Stacie Knight Download
Aug 9, 2018 2085 EX2085 - SEALED Declaration of Urs Schleuniger Download
Aug 9, 2018 2085 EX2085 - REDACTED Declaration of Urs Schleuniger Download
Aug 9, 2018 2086 EX2086 - SEALED Declaration of Tim Shaw Download
Aug 9, 2018 2087 EX2087 - REDACTED Declaration of Randall Stevens Download
Aug 9, 2018 2090 EX2090 - REDACTED Declaration of Marc Watrous Download
Aug 1, 2018 42 Decision - Granting Petitioner's Motion for Pro Hac Vice Admission of Mr. Leon Miniovich - 37 CFR 42.10 Download
Aug 1, 2018 40 Decision - Granting Petitioner's Motion for Pro Hac Vice Admission of Mr. Eric E. Lancaster - 37 CFR 42.10 Download
Aug 1, 2018 41 Decision - Granting Petitioner's Motion for Pro Hac Vice Admission of Mr. Amit H. Thakore - 37 CFR 42.10 Download
Jul 25, 2018 37 Petitioner's Updated Mandatory Notice Download
Jul 25, 2018 39 Motion for Pro Hac Vice Admission of Eric Lancaster, Amit Thakore and Leon Miniovich Download
Jul 25, 2018 38 Updated Exhibit List (7-25-18) Download
Jul 25, 2018 1057 EX 1057 Miniovich Declaration for PHV Download
Jul 25, 2018 1056 EX 1056 Thakore Declaration for PHV Download
Jul 25, 2018 1055 EX 1055 Lancaster Declaration for PHV Download
Jul 13, 2018 36 Petitioner's Updated Mandatory Notice Download
Jul 13, 2018 35 Petitioner's Updated Power Of Attorney Appointing Additional Counsel Download
Jul 10, 2018 33 Denying Patent Owners Request for Rehearing 37 C.F.R. sec(s) 42.71(d) Download
Jul 10, 2018 34 Granting Patent Owner's Motion for Pro Hac Vice Admission of Ms. Crystal Lohmann Parker 37 C.F.R. § 42.10 Download
Jun 25, 2018 31 Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Crystal Lohmann Parker Download
Jun 25, 2018 32 Notice of Deposition of Michael L. Grossbard, M.D. Download
Jun 25, 2018 2011 Declaration of Crystal Lohmann Parker in Support of Patent Owner's Unopposed Motion for Pro Hac Vice Admission Download
Jun 7, 2018 30 Notice of Deposition of Dr. Elena Massarotti Download
May 18, 2018 27 Patent Owner's Supplemental Mandatory Notice Download
May 18, 2018 29 Patent Owner's Brief Requesting Rehearing/Modification of Supplemental Institution Decision Download
May 18, 2018 28 Petitioner's Authorized Opposition To Patent Owner's Request For Rehearing Of The Board's May 4, 2018 Order Download
May 16, 2018 24 Joint Stipulation to Modify Due Dates 1 through 5 Download
May 16, 2018 25 Decision - Granting Petitioner's Motion for Pro Hac Vice Admission of Charles B. Klein - 37 CFR 42.10 Download
May 16, 2018 26 Decision - Granting Petitioner's Motion for Pro Hac Vice Admission of Eimeric Reig-Plessis - 37 CFR 42.10 Download
May 15, 2018 23 Modifying Scheduling Order - 37 CFR 42.5 Download
May 14, 2018 22 Order - Conduct of the Proceeding - 37 CFR 42.5 Download
May 4, 2018 21 Conduct of the proceeding Download
May 2, 2018 19 Petitioner's Service of Supplemental Evidence Download
May 2, 2018 20 Petitioner's Updated List of Exhibits (as of 2018.05.02) Download
Apr 24, 2018 18 Stipulation Regarding Due Dates 1 and 2 Download
Apr 18, 2018 16 Patent Owners Objections to Evidence Download
Apr 18, 2018 17 Petitioner's Objections To Patent Owner's Exhibits Download
Apr 4, 2018 15 Scheduling Order Download
Apr 4, 2018 14 Decision Institution of Inter Partes Review Download
Jan 31, 2018 13 Petitioner's Updated Mandatory Notice Download
Jan 26, 2018 12 Petitioner's Authorized Reply To Patent Owner's Preliminary Response Download
Jan 25, 2018 11 Order - Conduct of the Proceeding - 37 CFR 42.5 Download
Jan 18, 2018 9 Petitioner's Updated Exhibit List (as of January 18, 2018) Download
Jan 18, 2018 1053 Ex. 1053 - Declaration of Eimeric Reig-Plessis in Support of Motion for Pro Hac Vice Admission Download
Jan 18, 2018 1052 Ex. 1052 - Declaration of Charles B. Klein in Support of Motion for Pro Hac Vice Admission Download
Jan 18, 2018 10 PETITIONER'S UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF CHARLES B. KLEIN AND EIMERIC REIG-PLESSIS Download
Jan 5, 2018 8 Patent Owner's Preliminary Response Download
Jan 5, 2018 2002 Boardside "Chat with the Chief" presentation by Chief Administrative Patent Judge David P. Ruschke, titled "An Analysis of Multiple Petitions in AIA Trials," dated Oct. 24 2017 Download
Jan 5, 2018 2003 J.K. Jenkins & K.J. Hardy, Biological Modifier Therapy for the Treatment of Rheumatoid Arthritis, 323(4) Am. J. Med. Sci. 197-205 (2002) Download
Jan 5, 2018 2010 Declaration of Megan Raymond Download
Jan 5, 2018 2004 Rituxan (Rituximab) Prescribing Information dated February 2010 Download
Jan 5, 2018 2006 "Arthritis Foundation Statement on Rituximab for Rheumatoid Arthritis" submitted, on May 10, 2012, by Genentech, Inc. to the European Patent Office as an exhibit (D61) to an appeal in the Opposition Proceedings in EP 1613350 Download
Jan 5, 2018 2008 Expert Report of Professor Dr. Bernardus (Ben) A.C. Dijkmans that was submitted by Petitioner, Pfizer, Inc., in a validity action involving European Patent EP 1951304 Download
Jan 5, 2018 2009 Peter McLaughlin et al., Ritxuximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program, 16(8) J. of Clinical Oncology, 2825-33 (Aug. 1998) Download
Jan 5, 2018 2005 Stanley B. Cohen et al., Rituximab for Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy, 54(9) Arthritis & Rheumatism, 2793-2806 (Sept. 2006) Download
Jan 5, 2018 2001 International Application Publication No. WO 00/74718 A1 to David M. Goldberg et al. Download
Jan 5, 2018 2007 Prosecution History of U.S. Patent No. 7,976,838 Download
Dec 22, 2017 7 Supplemental Mandatory Note Download
Dec 22, 2017 6 Power of Attorney Download
Oct 5, 2017 5 Notice of Accord Filing Date Download
Sep 19, 2017 3 Power of Attorney Download
Sep 19, 2017 4 Patent Owner's Mandatory Notice Download
Aug 29, 2017 1049 Ex. 1049 - Tanya Doan & Elena Massarotti, "Rituximab," Drugs of Today, 41(12):785-797 (2005) ("Massarotti") Download
Aug 29, 2017 1038 Ex. 1038 - Patent Owner Preliminary Response, Celltrion, Inc. v. Genentech, Inc., IPR2016-01667 (U.S. Patent No. 7,976,838), Paper 13 (PTAB) Download
Aug 29, 2017 1034 Ex. 1034 - Part 4 - Declaration of Scott Bennett, Ph.D. Download
Aug 29, 2017 1034 Ex. 1034 - Part 4 - Declaration of Scott Bennett, Ph.D. Download
Aug 29, 2017 2 PETITION FOR INTER PARTES REVIEW Download
Aug 29, 2017 1046 Ex. 1046 - Michael E. Weinblatt et al., "Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis," N.E. J. Medicine, 312(13):818-822 (1985) ("Weinblatt") Download
Aug 29, 2017 1034 Ex. 1034 - Part 4 - Declaration of Scott Bennett, Ph.D. Download
Aug 29, 2017 1044 Ex. 1044 - David G. Maloney et al., "IDEC-C2B8: Results of a Phase I Multiple-Dose Trial in Patients with Relapsed Non-Hodgkin's Lymphoma," J. Clinical Oncology, 15(10):3266-3274 (1997) ("Maloney II") Download
Aug 29, 2017 1041 Ex. 1041 - Declaration of Michael L. Grossbard, M.D. Download
Aug 29, 2017 1043 Ex. 1043 - Michael L. Grossbard et al., "Anti-B4-blocked ricin: A Phase II Trial of 7 Day Continuous Infusion in Patients with Multiple Myeloma," Brit. J. Haematology, 102:509-515 (1998) ("Grossbard") Download
Aug 29, 2017 1045 Ex. 1045 - Press OW et al., "Monoclonal Antibody 1F5 (anti-CD20) Serotherapy of Human B Cell Lymphomas," Blood, 69:584-591 (1987) ("Press") Download
Aug 29, 2017 1032 Ex. 1032 - Darrell R. Anderson, U.S. Patent No. 5,736,137 (issued April 7, 1998) ("the '137 patent") Download
Aug 29, 2017 1047 Ex. 1047 - Daniel E. Furst & Joel M. Kremer, "Methotrexate in Rheumatoid Arthritis," Arthritis & Rheumatism, 31(3):305-314 (1988) ("Furst II") Download
Aug 29, 2017 1048 Ex. 1048 - Physicians' Desk Reference (55th ed. 2001) (excerpted), "Remicade (infliximab)" ("Remicade label") Download
Aug 29, 2017 1037 Ex. 1037 - Institution of Inter Partes Review, Boehringer Ingelheim Int'l GmBH v. Genentech, Inc., IPR2015-00417 (U.S. Patent No. 7,976,838), Paper 11 (PTAB) Download
Aug 29, 2017 1050 Ex. 1050 - Physicians' Desk Reference (55th ed. 2001) (excerpted), "Enbrel (etanercept)" ("Enbrel label") Download
Aug 29, 2017 1040 Ex. 1040 - Patent Owner Response (Redacted), Celltrion, Inc. v. Genentech, Inc. and Biogen, Inc., IPR2016-01614 (U.S. Patent No. 7,820,161), Paper 24 (PTAB) Download
Aug 29, 2017 1033 Ex. 1033 - Genentech, Inc. SEC Form 10-K for Period Ended 12/31/2008 Download
Aug 29, 2017 1036 Ex. 1036 - Patent Owner Preliminary Response, Boehringer Ingelheim Int'l GmBH v. Genentech, Inc., IPR2015-00417 (U.S. Patent No. 7,976,838), Paper 9 (PTAB) Download
Aug 29, 2017 1034 Ex. 1034 - Part 4 - Declaration of Scott Bennett, Ph.D. Download
Aug 29, 2017 1051 Ex. 1051 - Lisa A. Edwards, "Focus on ... Adalimumab: A Fully Human Monoclonal Anti-Tumor Necrosis Factor-Alpha Antibody," 38(5):248, 272-289 (2003) ("L. Edwards") Download
Aug 29, 2017 1035 Ex. 1035 - Patent Owner Preliminary Response, Boehringer Ingelheim Int'l GmBH v. Biogen Inc., IPR2015-00418 (U.S. Patent No. 8,329,172), Paper 11 (PTAB) Download
Aug 29, 2017 1039 Ex. 1039 - Decision Denying Institution of Inter Partes Review, Celltrion, Inc. v. Genentech, Inc., IPR2016-01667 (U.S. Patent No. 7,976,838), Paper 15 (PTAB) Download
Aug 29, 2017 1042 Ex. 1042 - P.L. Amlot et al., "A Phase I Study of an Anti-CD22-Deglycosylated Ricin A Chain Immunotoxin in the Treatment of B-cell Lymphomas Resistant to Conventional Therapy," Blood, 82(9): 2624-2633 (1993) Download
Aug 29, 2017 1024 Ex. 1024 - Pratik S. Multani & Michael L. Grossbard, "Monoclonal Antibody-Based Therapies for Hematologic Malignancies," J. Clinical Oncology, 16(11):3691-3710 (1998) ("Multani") Download
Aug 29, 2017 1031 Ex. 1031 - Sherine E. Gabriel, "The Epidemiology of Rheumatoid Arthritis," Rheumatic Disease Clinics of N. Am., 27(2):269-281 (2001) ("Gabriel") Download
Aug 29, 2017 1014 Ex. 1014 - Edwards et al., "Do Self-Perpetuating B Lymphocytes Drive Human Autoimmune Disease?" Immunology, 97:188-196 (1999) ("Edwards 1999") Download
Aug 29, 2017 1015 Ex. 1015 - Part 3 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1015 Ex. 1015 - Part 3 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1019 Ex. 1019 - Felson et al., "American College of Rheumatology: Preliminary Definition of Improvement in Rheumatoid Arthritis," Arthritis & Rheumatism, 38(6):727-735 (1995) ("Felson") Download
Aug 29, 2017 1002 Ex. 1002 - Declaration of Elena M. Massarotti, M.D. Download
Aug 29, 2017 1026 Ex. 1026 - Martine Chabaud et al., "The Combination of Tumor Necrosis Factor alpha Blockade with Interluekin-1 and Interluekin-17 Blockade ...," Arthritis & Rheumatism, 44(6):1293-1303 (2001) ("Chabaud") Download
Aug 29, 2017 1022 Ex. 1022 - Seymour et al., "Anti-TNF Agents for Rheumatoid Arthritis," J. Clinical Pharmacology 51:201-0208 (2001) ("Seymour") Download
Aug 29, 2017 1 Petitioner's Power of Attorney Download
Aug 29, 2017 1005 Ex. 1005 - Takemura et al., "T Cell Activation in Rheumatoid Synovium is B Cell Dependent," J. Immunology, 167:4710-4718 (2001) ("Takemura") Download
Aug 29, 2017 1004 Ex. 1004 - J.C.W. Edwards & G. Cambridge, "Sustained Improvement in Rheumatoid Arthritis Following a Protocol Designed to deplete B Lymphocytes," Rheumatology, 40:205-11 (2001) ("Edwards 2001") Download
Aug 29, 2017 1012 Ex. 1012 - Choy et al., "Therapeutic Benefit of Blocking Interleukin-6 Activity with an Anti-Interleukin-6 Receptor Monoclonal Antibody in Rheumatoid Arthritis," Arthritis & Rheumatism, 46(12):3143-3150 (2002) ("Choy II") Download
Aug 29, 2017 1030 Ex. 1030 - "Body Surface Area" in 1 Encyclopedia of Global Health (Yawae Zhang, ed.) 273-74 (2008) Download
Aug 29, 2017 1015 Ex. 1015 - Part 3 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1015 Ex. 1015 - Part 3 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1001 Ex. 1001 - Mark C. Benyunes, U.S. Patent No. 7,976,838 B2 Download
Aug 29, 2017 1009 Ex. 1009 - Physicians' Desk Reference (53rd ed. 1999) (excerpted), "Rituxan (Rituximab)" ("Rituxan label") Download
Aug 29, 2017 1006 Ex. 1006 - Klimiuk et al., "Tissue Cytokine Patterns Distinguish Variants of Rheumatoid Synovitis," Am. J. Pathology, 151(5): 1311-1319 (1997) ("Klimiuk") Download
Aug 29, 2017 1020 Ex. 1020 - James O'Dell, "Conventional DMARD Options for Patients with a Suboptimal Response to Methotrexate," J. Rheumatology, 62:21-26 (2001) ("O'Dell") Download
Aug 29, 2017 1017 Ex. 1017 - Joseph M Tuscano, "Successful of Infliximab-Refractory Rheumatoid Arthritis with Rituximab," Arthritis & Rheumatism, 46(12):3420 (2002) ("Tuscano") Download
Aug 29, 2017 1023 Ex. 1023 - Maloney et al., "IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients with Relapsed Low-Grade Non-Hodgkin's Lymphoma," Blood, 90(6):2188-2195 (1997) ("Maloney I") Download
Aug 29, 2017 1028 Ex. 1028 - Furst et al., "Access to Disease Modifying Treatments for Rheumatoid Arthritis Patients," Ann. Rheum. Disc. 58 (Supp. I):I129-130 (1999) ("Furst") Download
Aug 29, 2017 1021 Ex. 1021 - Joel M. Kremer, "Rational Use of New and Existing Disease-Modifying Agents in Rheumatoid Arhtritis," Ann. Internal Med., 134(8):695-706 (2001) ("Kremer") Download
Aug 29, 2017 1018 Ex. 1018 - Marc Feldmann, "Development of anti-TNF Therapy for Rheumatoid Arthritis," Nature 2(5):364-371 (2002) ("Feldmann") Download
Aug 29, 2017 1016 Ex. 1016 - De Vita et al., "Efficacy of Selective B Cell Blockade in the Treatment of Rheumatoid Arthritis: Evidence for a Pathogenic Role of B Cells," Arthritis & Rheumatism, 46(8):2029-2033 (2002) ("De Vita") Download
Aug 29, 2017 1003 Ex. 1003 - Edwards et al, "Efficacy and Safety of Rituximab, a B-Cell Targeted Chimeric Monoclonal Antibody ("Edwards 2002) Download
Aug 29, 2017 1015 Ex. 1015 - Part 3 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1007 Ex. 1007 - Ulfgren et al., "Systemic Anti-Tumor Necrosis Factor alpha Therapy in Rheumatoid Arthritis Down-Regulates Synovial Tumor Necrosis Factor alpha Synthesis," Arthritis & Rheumatism, 43(11):2391-2396 (2000) ("Ulfgren") Download
Aug 29, 2017 1013 Ex. 1013 - J.C.W. Edwards & G. Cambridge, "Rheumatoid Arthritis: The Predictable Effect on Small Immune Complexes in Which Antibody is also Antigen," Br. J. Rheumatology, 37:126-130 (1998) ("Edwards 1998") Download
Aug 29, 2017 1011 Ex. 1011 - Ernest H.S. Choy & Gabriel S. Panayi, "Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis," N.E. J. Med., 344(12):907-916 (2001) ("Choy I") Download
Aug 29, 2017 1029 Ex. 1029 - "Body Surface Area," in Arnold E. Bender & David A. Bender, A Dictionary of Food and Nutrition 51-52 (1995) Download
Aug 29, 2017 1027 Ex. 1027 - Ravinder N. Maini & Marc Feldmann, "How Does Infliximab Work in Rheumatoid Arthritis?" Arthritis Res. 4(Supp. 2):S22-28 (2002) ("Maini") Download
Aug 29, 2017 1008 Ex. 1008 - Curd et al., WO 00/67796, (published Nov. 16, 2000) ("Curd") Download
Aug 29, 2017 1010 Ex. 1010 - American College of Rheumatology, "Guidelines for the Management of Rheumatoid Arthritis: 2002 Update," Arthritis & Rheumatism, 46(2):328-346 (2002) ("ACR") Download
Aug 29, 2017 1025 Ex. 1025 - Weyand et al., "Cell-Cell Interactions in Synovitis: Interactions Between T Cells and B Cells in Rheumatoid Arthritis," Arthritis Research, 2(6):457-463 (2000) ("Weyand") Download
Aug 29, 2017 1015 Ex. 1015 - Part 2 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1015 Ex. 1015 - Part 4 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1015 Ex. 1015 - Part 5 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1015 Ex. 1015 - Part 1 - Excerpts from Vols. 1 & 2 Kelley's Textbook of Rheumatology, 6th Ed. (Ruddy et al., eds.) (2001) ("Kelley") Download
Aug 29, 2017 1034 Ex. 1034 - Part 3 - Declaration of Scott Bennett, Ph.D. Download
Aug 29, 2017 1034 Ex. 1034 - Part 1 - Declaration of Scott Bennett, Ph.D. Download
Aug 29, 2017 1034 Ex. 1034 - Part 2 - Declaration of Scott Bennett, Ph.D. Download
Menu